Chembond Material Technologies Ltd
NSE: CHEMBOND BSE: 530871
Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]
₹184
52W: ₹105 — ₹309
PE 29.3 · Book ₹127 · +45% vs bookMarket Cap₹248 Cr
Stock P/E29.3Price to Earnings
ROCE6.89%Return on Capital
ROE5.08%Return on Equity
Div. Yield0.94%Face Value ₹5
Strengths
- +Company is almost debt free.
Weaknesses
- −Company has a low return on equity of 6.39% over last 3 years.
- −Working capital days have increased from 69.5 days to 101 days
Shareholding Pattern
Promoters68.08%
FIIs0.61%
DIIs0.74%
Public30.58%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.56% | 67.61%▲0.0 | 67.63%▲0.0 | 67.65%▲0.0 | 67.65% | 67.65% | 67.72%▲0.1 | 68.08%▲0.4 |
| FIIs | 0.66% | 0.69%▲0.0 | 0.81%▲0.1 | 0.61%▼0.2 | 0.61% | 0.61% | 0.61% | 0.61% |
| DIIs | 1.21% | 1.18%▼0.0 | 1.26%▲0.1 | 1.32%▲0.1 | 1.13%▼0.2 | 0.74%▼0.4 | 0.74% | 0.74% |
| Public | 30.56% | 30.52%▼0.0 | 30.3%▼0.2 | 30.42%▲0.1 | 30.6%▲0.2 | 31%▲0.4 | 30.93%▼0.1 | 30.58%▼0.4 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.4 | 40.5 | 39.56 | 43.02 | 44.18 | 44.44 | 48.92 | 48.93 | 52.21 | 60.08 |
| Expenses | 13.02 | 37.34 | 35.4 | 40.32 | 40.99 | 41.34 | 46.27 | 46.24 | 49.97 | 55.31 |
| Operating Profit | -0.62 | 3.16 | 4.16 | 2.7 | 3.19 | 3.1 | 2.65 | 2.69 | 2.24 | 4.77 |
| OPM % | -5% | 7.8% | 10.52% | 6.28% | 7.22% | 6.98% | 5.42% | 5.5% | 4.29% | 7.94% |
| Net Profit | 1.5 | 1.7 | 5.52 | 6.34 | 2.4 | 2.97 | 3.17 | 2.63 | 0.04 | 1.91 |
| EPS ₹ | 1.12 | 1.27 | 4.12 | 4.73 | 1.79 | 2.22 | 2.37 | 1.96 | 0.03 | 1.43 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹210Cr, up 22.8% YoY. OPM at 6%.
Debt Position
Borrowings at ₹0Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.
Capex Cycle
CWIP at ₹2Cr (5% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.74% (+0.05pp change). FIIs: 0.61% (+0.04pp change). Promoters hold 68.08%.
Margin & Efficiency
ROCE declining from 11% (Mar 2015) to 7% (Mar 2026). Working capital days: 101.
Valuation
PE 29.3x with 6.89% ROCE. Price is 45% above book value of ₹127. Dividend yield: 0.94%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 20h - Submission of newspaper advertisement - Audited Financial Results of the Company for the quarter and year ended march 31,2026.
- Board Meeting Outcome for Outcome Of Board Meeting 2d - Board approved FY26 audited results and recommended Rs.2 dividend per share, subject to AGM approval.
- Compliances-Reg.24(A)-Annual Secretarial Compliance 14 May - Annual Secretarial Compliance Report for FY2026; company reported full compliance.
- Board Meeting Intimation for Intimation Of Meeting Of Board Of The Company Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015. 7 May - Board to meet on May 15, 2026 to approve FY26 audited results and consider dividend.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1 May - Newspaper advertisements of notice regarding Second 100 Days campaign - Saksham Niveshak
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse